Erythromycin Panpharma

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin;  

Disponible depuis:

Multichem NZ Limited

Dosage:

1 g

forme pharmaceutique:

Powder for infusion

Composition:

Active: Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin  

Type d'ordonnance:

Prescription

indications thérapeutiques:

Upper respiratory tract infections caused by Streptococcus pyogenes (Group A beta haemolytic streptococci); Lower respiratory tract infections caused by Streptococcus pyogenes (Group A betahaemolytic streptococci); Skin and skin structure infections caused by Streptococcus pyogenes.

Descriptif du produit:

Package - Contents - Shelf Life: Vial, glass, 20 mL glass vial type III, in a cardboard carton - 1 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 10 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 25 dose units - 3 years from date of manufacture stored at or below 30°C protect from light

Date de l'autorisation:

2017-08-14